Yahoo
NSE - Delayed Quote INR

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

1,899.00 -17.00 (-0.89%)
At close: September 4 at 3:15:04 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
596,175,900
582,201,100
520,412,500
477,584,500
432,788,700
Cost of Revenue
133,215,400
131,731,400
121,975,100
120,696,600
119,424,200
Gross Profit
462,960,500
450,469,700
398,437,400
356,887,900
313,364,500
Operating Expense
325,163,400
314,521,500
272,625,400
252,207,600
220,590,900
Operating Income
137,797,100
135,948,200
125,812,000
104,680,300
92,773,600
Net Non Operating Interest Income Expense
5,512,200
5,760,900
9,987,700
7,844,400
2,125,400
Pretax Income
160,449,200
151,188,800
137,521,300
110,878,900
94,084,300
Tax Provision
38,722,200
35,543,600
27,720,300
14,394,500
8,475,900
Net Income Common Stockholders
120,955,800
114,794,200
109,290,400
95,763,800
84,735,800
Diluted NI Available to Com Stockholders
120,955,800
114,794,200
109,290,400
95,763,800
84,735,800
Basic EPS
50.40
47.80
45.60
39.90
35.30
Diluted EPS
50.40
47.80
45.60
39.90
35.30
Basic Average Shares
2,397,792.60
2,399,334.97
2,399,334.97
2,399,334.97
2,399,334.97
Diluted Average Shares
2,397,792.60
2,399,334.97
2,399,334.97
2,399,334.97
2,399,334.97
Rent Expense Supplemental
--
994,000
777,400
734,300
588,700
Total Expenses
458,378,800
446,252,900
394,600,500
372,904,200
340,015,100
Net Income from Continuing & Discontinued Operation
120,955,800
114,794,200
109,290,400
95,763,800
84,735,800
Normalized Income
119,733,213.28
118,257,814
110,620,662.63
99,336,455
86,386,834.68
Interest Income
--
9,150,000
12,301,300
10,229,100
3,845,400
Interest Expense
3,637,800
3,389,100
2,313,600
2,384,700
1,720,000
Net Interest Income
5,512,200
5,760,900
9,987,700
7,844,400
2,125,400
EBIT
164,087,000
154,577,900
139,834,900
113,263,600
95,804,300
EBITDA
193,847,200
183,956,400
165,588,800
138,831,500
121,108,600
Reconciled Cost of Revenue
133,215,400
131,731,400
121,975,100
120,696,600
119,424,200
Reconciled Depreciation
29,760,200
29,378,500
25,753,900
25,567,900
25,304,300
Net Income from Continuing Operation Net Minority Interest
120,955,800
114,794,200
109,290,400
95,763,800
84,735,800
Total Unusual Items Excluding Goodwill
1,611,500
-4,527,600
-1,666,100
-4,106,500
-1,814,500
Total Unusual Items
1,611,500
-4,527,600
-1,666,100
-4,106,500
-1,814,500
Normalized EBITDA
192,235,700
188,484,000
167,254,900
142,938,000
122,923,100
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
388,913.28
-1,063,986
-335,837.37
-533,845
-163,465.32
3/31/2023 - 1/1/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: